AzTrials
AzTrials

Peri-implant Soft Tissue HealingNCT07031232

Comparative Clinical Study of Conventional vs Customized Healing Abutments in Dental Implantology

A study testing Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments in people with Peri-implant Soft Tissue Healing and Soft Tissue Management in Subcrestal Dental Implants, run by University of Valencia at 1 site in Spain.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This clinical study evaluates how different healing abutment designs influence the healing and preservation of the soft tissues surrounding dental implants. Healing abutments are temporary components placed on implants during the healing phase to help shape the gum tissue before placing the final crown or prosthesis. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteSpain
Study dates
1 Jul 2025to 31 Jul 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older.
  • Patients requiring a single dental implant in a healed posterior site (maxilla or mandible).
  • Presence of at least 2 mm of keratinized mucosa at the implant site.
  • Healed alveolar ridge with sufficient bone volume for implant placement without need for guided bone regeneration.
  • Good general and oral health, with controlled plaque and bleeding indices.
  • Insertion torque ≥ 30 Ncm at the time of implant placement.
  • Willingness to comply with study protocol and attend scheduled follow-up visits.
  • Signed informed consent.

Who cannot join

  • Smoking more than 10 cigarettes per day.
  • Uncontrolled systemic diseases (e.g., uncontrolled diabetes, immunosuppression).
  • History of head or neck radiation therapy.
  • Current or recent use of bisphosphonates.
  • Active periodontal disease or peri-implant infection.
  • Severe parafunctional habits (e.g., bruxism, clenching).
  • Pregnant or breastfeeding women.
  • Previous implant failure at the intended site.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Universitat de València

    Valencia, Valencia, 46010

Other trials in Spain

About this study

Official title: Assessment of Peri-implant Soft Tissue Modifications Following the Use of Customized Healing Abutments on Subcrestally Placed Implants

This clinical study evaluates how different healing abutment designs influence the healing and preservation of the soft tissues surrounding dental implants. Healing abutments are temporary components placed on implants during the healing phase to help shape the gum tissue before placing the final crown or prosthesis. The way these components interact with the gum tissue may affect the long-term stability, volume, and aesthetics of the peri-implant soft tissue.

All participating patients will receive bone-level dental implants placed approximately 2 mm below the bone crest (subcrestal position). The study will include three groups of patients, each receiving a different type of healing abutment:

Read more

Group 1 (Control): will receive a standard cylindrical healing abutment.

Group 2: will receive a wide healing abutment with an enlarged base to support more soft tissue volume.

Group 3: will receive a customized healing abutment designed using digital intraoral scanning and CAD/CAM technology, intended to replicate the final prosthetic emergence profile.

The goal is to evaluate which type of healing abutment helps to preserve the natural volume and shape of the gum tissue most effectively during the healing period. The primary focus will be on measuring changes in soft tissue volume and thickness around the implants over time.

Participants will undergo digital intraoral scans before surgery and at 3, 6, and 12 months after implant placement. These scans will be used to assess how the gum tissue changes in response to each type of abutment using 3D analysis and software-based measurements.

This study is important because maintaining healthy and stable soft tissue around dental implants plays a crucial role in achieving successful, long-lasting, and aesthetically pleasing results. By understanding how healing abutment design affects tissue healing, clinicians may be better equipped to select the most appropriate healing protocol for each patient.

Read the detailed description

Background and Rationale:

Peri-implant soft tissue health and stability are essential factors influencing the long-term success of dental implants, especially in terms of aesthetic outcomes and biological integration. A well-formed and stable mucosal seal around the implant protects the underlying bone, supports tissue homeostasis, and contributes to the overall functional and esthetic result of implant-supported prostheses.

Healing abutments are temporary components used during the transgingival healing phase to help shape the emergence profile and guide soft tissue adaptation prior to final prosthetic restoration. The design, diameter, and customization of the healing abutment may significantly affect peri-implant soft tissue volume, thickness, contour, and recession patterns. Recent research has suggested that minimizing disruption to the peri-implant mucosa (i.e., using a one abutment-one time approach) and optimizing soft tissue support during healing can result in improved tissue preservation and enhanced esthetic outcomes.

However, there is limited clinical evidence comparing the effect of different healing abutment designs-particularly standard, wide, and customized abutments-on the volumetric and linear changes in peri-implant soft tissues, especially when implants are placed subcrestally in healed ridges. This study aims to address that gap through a randomized controlled clinical trial using modern digital tools for volumetric analysis.

Study Objectives:

Primary Objective:

To compare the volumetric changes in peri-implant soft tissue among three different healing abutment designs (standard, wide, and customized) placed over subcrestally positioned bone-level implants in healed ridges.

Secondary Objectives:

To assess the linear changes in gingival margin position and mucosal thickness.

To evaluate the influence of healing abutment design on the stability of the emergence profile.

To explore potential correlations between abutment geometry and soft tissue recession or contour collapse.

To analyze patient-reported outcomes related to esthetic satisfaction and perceived tissue healing.

Study Design:

This is a single-center, randomized, controlled, parallel-group clinical trial with three intervention arms. Thirty adult patients will be recruited and randomly allocated into one of the three study groups (n = 25 per group). All patients will receive a single bone-level dental implant in a posterior maxillary or mandibular healed site, placed 2 mm subcrestally following a one abutment-one time protocol with platform switching.

Study Groups:

Group 1 (Control Group):

Standard cylindrical titanium healing abutment (prefabricated, regular diameter).

Group 2 (Wide Abutment Group):

Prefabricated wide healing abutment with increased diameter for broader mucosal support.

Group 3 (Customized Abutment Group):

Customized healing abutment fabricated in composite using preformed emergence profiles to replicate the ideal emergence profile of the final prosthesis.

All healing abutments will be placed at the time of implant surgery and will not be disconnected during the healing process, in accordance with the one abutment-one time philosophy.

Inclusion Criteria:

Adults aged 18 years or older.

Non-smoking or light-smoking patients (<10 cigarettes/day).

Good general and oral health.

Healed posterior edentulous site requiring a single implant.

Presence of ≥2 mm of keratinized mucosa.

Bone volume sufficient for subcrestal implant placement without grafting.

Willingness to participate and follow the study protocol.

Exclusion Criteria:

Active periodontal or peri-implant disease.

Systemic diseases affecting healing (e.g., uncontrolled diabetes).

Use of bisphosphonates or immunosuppressants.

Pregnancy or lactation.

History of radiation therapy in the head and neck.

Parafunctional habits (e.g., severe bruxism).

Intervention Protocol:

Surgical Procedure:

All implants will be placed 2 mm subcrestally using a guided surgical protocol.

After implant placement, patients will receive the assigned healing abutment (standard, wide, or customized) immediately.

The abutment will remain in place throughout healing and prosthetic phases.

Digital Workflow:

Intraoral scans (STL files) will be obtained at:

T0 (baseline, immediately post-surgery),

T1 (3 months),

T2 (6 months),

T3 (12 months).

The STL files will be superimposed using best-fit alignment algorithms for accurate 3D comparisons.

Tissue Measurement and Analysis:

Soft tissue changes will be measured in terms of:

Volumetric displacement (mm³) using specialized 3D software.

Linear changes in soft tissue thickness and mucosal margin level (mm).

Qualitative heat maps and color-coded deviations will be used to visualize soft tissue gain/loss.

Primary Outcome Measure:

Change in buccal soft tissue volume (mm³) from baseline to 3 months, based on digital 3D superimposition and volumetric analysis.

Secondary Outcome Measures:

Linear change in mucosal thickness (mm) at 3, 6, and 12 months.

Gingival margin displacement (mm) at buccal and interproximal points.

Stability of the emergence profile during provisional and final restoration stages.

Patient-reported esthetic satisfaction using a visual analog scale (VAS).

Statistical Analysis:

Descriptive and inferential statistics will be used. Continuous variables will be analyzed with repeated measures ANOVA or mixed models. Categorical variables will be evaluated using chi-square or Fisher's exact tests. A p-value < 0.05 will be considered statistically significant.

Sample size was calculated to detect a clinically significant difference of 1 mm³ in soft tissue volume change, with a standard deviation of 0.8, α = 0.05, and 80% power, resulting in 10 subjects per group.

Ethical Considerations:

The study will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines. Ethical approval has been or will be obtained from the institutional review board. Informed consent will be obtained from all participants prior to any study-related procedure.

Expected Outcomes and Significance:

This clinical trial aims to clarify how the design of healing abutments-particularly customized CAD/CAM components-affects the healing and dimensional stability of peri-implant soft tissues. Results from this study could support evidence-based decision-making regarding abutment selection in clinical practice, especially in aesthetic-sensitive or high-demand cases. Improved tissue preservation could lead to better prosthetic outcomes and patient satisfaction.

Being tested
Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing AbutmentsProcedure or surgery

    All participants will receive a single bone-level dental implant placed in a healed posterior site of the maxilla or mandible. The implants will be placed using a biological drilling protocol and inserted with a final torque of at least 30 Ncm. A 2 mm transmucosal one-piece abutment (mono-block) will be connected at the time of surgery, following a one abutment-one time philosophy.

    Each patient will receive a healing abutment immediately after implant placement according to their allocated study group (standard, wide, or customized). The assigned healing abutment will not be removed throughout the healing period. All procedures will be carried out under local anesthesia in a standard clinical setting.

Study groups in NCT07031232
Study groupRoleWhat they receive
Standard Healing Abutment GroupExperimentalParticipants in this group will receive a conventional, prefabricated cylindrical titanium healing abutment placed immediately after implant surgery. The abutment will remain in place throughout the healing period, following a one abutment-one time protocol.
Receives: Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments
Wide Healing Abutment GroupExperimentalParticipants in this group will receive a prefabricated wide healing abutment with an increased diameter designed to provide broader mucosal support. The abutment will be placed immediately after surgery and will not be removed during healing.
Receives: Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments
Customized Healing Abutment GroupExperimentalParticipants in this group will receive a customized healing abutment fabricated with composite using a preform-phantoma. The abutment will replicate the desired emergence profile of the final prosthesis. It will be placed immediately after surgery and left in place during the healing phase.
Receives: Procedure: Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dimensional changes in the peri-implamt soft tissue

    Soft tissue changes will be assessed using digital intraoral scans obtained at baseline, immediately after surgery, and at 3, 6, and 12 months. STL files will be superimposed using 3D analysis software based on stable anatomical landmarks. Volumetric and linear changes will be calculated within defined buccal and interproximal regions of interest (ROIs). Parameters include soft tissue volume (mm³), thickness (mm), and gingival margin displacement. Color-coded deviation maps will visualize contour stability. All measurements will be performed in duplicate by calibrated, blinded evaluators. This method offers accurate, reproducible, and non-invasive assessment of peri-implant soft tissue dynamics.

    Measured: Preoperative, the day of the intervention and a follow up until 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2025
  2. Study start1 Jul 2025
  3. Primary completion31 Oct 2026 (estimated)
  4. Study completion31 Jul 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07031232
Sponsor's protocol ID
UV-INV_ETICA-3494808
Status last verified
Jul 2026
First submitted
12 Jun 2025
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Perez A, Caiazzo A, Valente NA, Toti P, Alfonsi F, Barone A. Standard vs customized healing abutments with simultaneous bone grafting for tissue changes around immediate implants. 1-year outcomes from a randomized clinical trial. Clin Implant Dent Relat Res. 2020 Feb;22(1):42-53. doi: 10.1111/cid.12871. Epub 2019 Dec 3.

    PubMed 31797548
  • Chokaree P, Poovarodom P, Chaijareenont P, Rungsiyakull P. Effect of Customized and Prefabricated Healing Abutments on Peri-Implant Soft Tissue and Bone in Immediate Implant Sites: A Randomized Controlled Trial. J Clin Med. 2024 Feb 2;13(3):886. doi: 10.3390/jcm13030886.

    PubMed 38337580
  • Puisys A, Auzbikaviciute V, Vindasiute-Narbute E, Pranskunas M, Razukevicus D, Linkevicius T. Immediate implant placement vs. early implant treatment in the esthetic area. A 1-year randomized clinical trial. Clin Oral Implants Res. 2022 Jun;33(6):634-655. doi: 10.1111/clr.13924. Epub 2022 Apr 7.

    PubMed 35318752
  • Akin R, Chapple AG. Clinical Advantages of Immediate Posterior Implants With Custom Healing Abutments: Up to 8-Year Follow-Up of 115 Cases. J Oral Maxillofac Surg. 2022 Dec;80(12):1952-1965. doi: 10.1016/j.joms.2022.08.014. Epub 2022 Aug 30.

    PubMed 36155739

Questions about this trial

What is this clinical trial studying?

A study testing Bone-Level Implant Placement with Transmucosal Abutment and One Abutment-One Time Protocol Using Healing Abutments in people with Peri-implant Soft Tissue Healing and Soft Tissue Management in Subcrestal Dental Implants, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dimensional changes in the peri-implamt soft tissue (time frame: Preoperative, the day of the intervention and a follow up until 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07031232, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in